Key result
Peripheral fat distribution in women is linked to ~51% lower odds of composite cardiometabolic disease.
Why the study?
Body fat distribution may be more relevant for cardiometabolic risk than total adiposity, motivating evaluation of the DXA-defined peripheral fat distribution phenotype associated with lipedema across different body fat levels in women.
Does a peripheral fat distribution phenotype (leg fat to total fat ratio ≥ 0.383) reduce the odds of a composite cardiometabolic outcome in women aged 20-59 years?
Cross-Sectional (n=4,986)
Does a peripheral fat distribution phenotype (leg fat to total fat ratio ≥ 0.383) reduce the odds of a composite cardiometabolic outcome in women aged 20-59 years?
In women aged 20-59 years, a DXA-derived peripheral (gynoid) fat distribution phenotype associated with lipedema is linked to significantly lower odds of prevalent cardiometabolic disease across varying levels of total body fat.
Answers are grounded in this paper and cite their sources.
Peripheral fat phenotype may indicate lower cardiometabolic risk in women; hypothesis-generating and should not yet change practice.
Background Body fat distribution may be more relevant for cardiometabolic risk than total adiposity. The Buso criterion uses dual-energy X-ray absorptiometry (DXA) to identify a peripheral (gynoid) fat distribution pattern associated with lipedema, without establishing a clinical diagnosis of the condition. Objectives To evaluate the association between the peripheral fat distribution phenotype and the composite cardiometabolic outcome in women with different levels of body fat. Methods Cross-sectional study of 4,986 women aged 20-59 years from the National Health and Nutrition Examination Survey (NHANES) 2011-2018. The phenotype was defined as the ratio of leg fat to total fat ≥ 0.383, as measured by DXA. The composite outcome included diabetes, hypertension, high cholesterol, prediabetes, and cardiovascular disease. Survey-weighted logistic regression models were used, with analyses stratified by body fat and correction for multiple comparisons. Results The phenotype was associated with lower odds of the composite outcome (odds ratio = 0.49; 95% CI, 0.41-0.60; p < 0.001). There was no evidence of statistically significant interaction with the total fat category (p = 0.110). In the 25-38% body fat range, the outcome had a prevalence of 22.3% in women with the phenotype versus 49.4% in those without the phenotype. Conclusions The peripheral fat distribution phenotype was associated with lower odds of the composite cardiometabolic outcome across different levels of body fat. The cross-sectional design does not allow establishing temporality or causality.
No takes yet. Share an insight, caveat, or question.
Amato et al. (2026) conducted a cross-sectional in Cardiometabolic disease and peripheral fat distribution (lipedema-associated phenotype) (n=4,986). Peripheral fat distribution phenotype (ratio of leg fat to total fat >= 0.383 by DXA) vs. Without peripheral fat distribution phenotype (ratio of leg fat to total fat < 0.383) was evaluated on Composite cardiometabolic outcome (diabetes, hypertension, high cholesterol, prediabetes, and cardiovascular disease) (OR 0.49, 95% CI 0.41-0.60, p=<0.001). A peripheral fat distribution phenotype in women was associated with lower odds of composite cardiometabolic disease.
Synapse has enriched 10 related papers. Consider them for comparative context: